Maxim Initiates NeuroBo Pharmaceuticals With Buy Rating, $10 Price Target
NeuroBo Pharmaceuticals Analyst Ratings
Maxim Group Initiates Coverage On NeuroBo Pharmaceuticals With Buy Rating, Announces Price Target of $10
NeuroBo Pharmaceuticals Analyst Ratings
No Data